2022-08-20 高雄萬豪酒店 10F皇喜會議室 10D-2
時間主題講者座長摘要簡報
13:10 ~ 13:30
瀏覽海報時間
All
張英勛,
王紹全
13:30 ~ 13:34
MP03-01: Treatment strategy for dialysis patient with urothelial carcinoma
楊浩誌
張英勛,
王紹全
13:34 ~ 13:38
MP03-02: The pan-immune-inflammation value is a new prognostic biomarker in upper tract urothelial carcinoma
郁廉靖
張英勛,
王紹全
13:38 ~ 13:42
MP03-03: New treatment strategies for overcoming the chemoresistance of urothelial carcinoma
許富順
張英勛,
王紹全
13:42 ~ 13:46
MP03-04: Cost-effectiveness analysis of immune checkpoint inhibitors in metastatic urothelial cancer, a single-center retrospective study
楊立宇
張英勛,
王紹全
13:46 ~ 13:50
MP03-05: Aquaporins are involved in tumor formation and may potentially act as a therapeutic target in urothelial carcinoma
葉碧雯
張英勛,
王紹全
13:50 ~ 13:54
MP03-06: Effects of variant histology on the oncology outcomes of patients with upper tract urothelial carcinoma after radical nephroureterectomy
于宗玉
張英勛,
王紹全
13:54 ~ 13:58
MP03-07: The role of lymph node dissection in patients with upper tract urothelial carcinoma without clinical lymph node metastasis undergoing radical nephroureterectomy
邱泰樺
張英勛,
王紹全
13:58 ~ 14:02
MP03-08: Blockade of the autophagic flux suppresses antitumor immunity via programmed death ligand-1 up-regulation in bladder cancer
蔡德甫
張英勛,
王紹全
14:02 ~ 14:06
MP03-09: Second primary malignancy risk in patients with upper urinary tract urothelial carcinoma in Taiwan - a nationwide population-based study
郭育任
張英勛,
王紹全
14:06 ~ 14:10
MP03-10: Establishing predictive model of renal function after unilateral nephroureterectomy in upper tract urothelial carcinoma patients
蘇楷森
張英勛,
王紹全